ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Indole-3-Propionic Acid as a Potential Therapeutic Agent for Sepsis-Induced Gut Microbiota Disturbance

Fang, Heng; Fang, Miaoxian; Wang, Yirong; Zhang, Huidan; Li, Jiaxin; Chen, Jingchun; Wu, Qingrui; He, Linling; Xu, Jing; Deng, Jia; Liu, Mengting; Deng, Yiyu*; Chen, Chunbo*广东省人民医院; 广东省心血管病研究所; 南方医科大学
Microbiology Spectrum2022-6DOI: 10.1128/spectrum.00125-22
22被引10阅读
引用收藏
分享

摘要

The role of gut microbiota in the pathophysiology of sepsis is gaining increasing attention and developing effective and safe sepsis therapies targeting intestinal microorganisms is promising. Given the safety of probiotic supplementation or fecal microbiota transplantation in critically ill patients, identifying an abiotic agent to regulate the intestinal microbiota of septic patients is of clinical significance. @@@ The effects of using gut microbiota metabolites instead of live microorganisms to modulate sepsis-induced gut dysbiosis remain largely unknown. We assessed the effects of microbiota metabolite indole-3-propionic acid (IPA) on gut microbiota in mice during sepsis. Sepsis models were constructed by cecal ligation and puncture (CLP) methods. Fecal microbiota composition analysis was performed to characterize the gut microbiota composition. Fecal microbiota transplantation was performed to validate the roles of gut microbiota on sepsis progression. IPA-treated mice exhibited lower serum inflammatory mediator levels and a higher survival rate than those of saline-treated mice after modeling of sepsis, which were negated in the presence of antibiotics. Compared with saline-treated mice after modeling, IPA-treated mice showed a markedly different intestinal microbiota composition, with an enrichment of Bifidobacteriaceae family and a depletion of Enterobacteriaceae family. Mice gavaged with postoperative feces from IPA-treated animals displayed better survival than mice gavaged with feces from saline-treated animals. Overall, these data suggest that IPA offers a microbe-modulated survival advantage in septic mice, indicating that some microbiota metabolites could replace live microorganisms as potential options for regulation of sepsis-induced gut dysbiosis. IMPORTANCE The role of gut microbiota in the pathophysiology of sepsis is gaining increasing attention and developing effective and safe sepsis therapies targeting intestinal microorganisms is promising. Given the safety of probiotic supplementation or fecal microbiota transplantation in critically ill patients, identifying an abiotic agent to regulate the intestinal microbiota of septic patients is of clinical significance. This study revealed that IPA, a microbiota-generated tryptophan metabolite, ameliorated sepsis-induced mortality and decreased the serum levels of proinflammatory cytokines by modulating intestinal microbiota. Although IPA did not increase the abundance and diversity of the microbiota of septic mice, it significantly decreased the number of Enterobacteriaceae family. These findings indicate that a specific microbiota metabolite (e.g., IPA) can mediate the intestinal microbiota apart from FMT or probiotics.

学科与关键词

关键词
sepsisgut microbiotaindole-3-propionic acidmicrobiota metabolite
相关
加载中…
  • Gut microbiota-derived indole 3-propionic acid partially activates aryl hydrocarbon receptor to promote macrophage phagocytosis and attenuate septic injury
    Huang, Zhi-Bin; Hu, Zhen; Lu, Chen-Xin; Luo, Si-Dan; Chen, Yu; Zhou, Zhi-Peng; Hu, Jing-Juan; Zhang, Fang-Ling; Deng, Fan*; Liu, Ke-Xuan*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1015386.被引 9
  • Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice
    Fang, Heng; Wang, Yirong; Deng, Jia; Zhang, Huidan; Wu, Qingrui; He, Linling; Xu, Jing; Shao, Xin; Ouyang, Xin; He, Zhimei; Zhou, Qiuping; Wang, Huifang; Deng, Yiyu*; Chen, Chunbo*mSystems, 2022, 7(3).被引 16
  • Gut microbiota disruption during sepsis and the influence of innate metabolites on sepsis prognosis
    Ma, Xiaohui; Jia, Xiaonan; Peng, Yahui; Li, Xueting; Wang, Changsong; Yu, Kaijiang*INTERNATIONAL MICROBIOLOGY, 2023, 26(4): 929-938.
查看全部 →

发表信息

论文状态
公开发表
期刊
Microbiology Spectrum
发表日期
2022-06
卷期
第 10 卷, 第 3 期
DOI
10.1128/spectrum.00125-22
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82172162]; Maoming Science and Technology Project [2020255]; Guangdong Province High-Level Hospital Construction Project of Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences [DFJH2020028]; major program of Summit Project

作者

  • F

    Fang, Heng (第一作者)

    guangdong prov peoples hosp · guangdong cardiovasc inst · 2 · southern med univ

  • F

    Fang, Miaoxian

    guangdong cardiovasc inst · guangdong prov peoples hosp

查看全部 13 位作者收起作者
  • W

    Wang, Yirong

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • Z

    Zhang, Huidan

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • L

    Li, Jiaxin

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • C

    Chen, Jingchun

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • W

    Wu, Qingrui

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • H

    He, Linling

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • X

    Xu, Jing

    guangdong prov peoples hosp · 2 · southern med univ

  • D

    Deng, Jia

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • L

    Liu, Mengting

    guangdong prov peoples hosp

  • D

    Deng, Yiyu (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

  • C

    Chen, Chunbo (通讯)

    guangdong prov peoples hosp · guangdong cardiovasc inst · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417